Kate Lapane to Hypertension
This is a "connection" page, showing publications Kate Lapane has written about Hypertension.
Pedone C, Lapane KL. Generalizability of guidelines and physicians' adherence. Case study on the Sixth Joint National Commitee's guidelines on hypertension. BMC Public Health. 2003 Jul 21; 3:24.
Gambassi G, Lapane K, Sgadari A, Landi F, Carbonin P, Hume A, Lipsitz L, Mor V, Bernabei R. Prevalence, clinical correlates, and treatment of hypertension in elderly nursing home residents. SAGE (Systematic Assessment of Geriatric Drug Use via Epidemiology) Study Group. Arch Intern Med. 1998 Nov 23; 158(21):2377-85.
Derby CA, Lapane KL, Hume AL, Babour MM, Carleton RA. Is cigarette smoking an effect modifier of the relation between antihypertensive therapy and blood lipids? Epidemiology. 1997 Jan; 8(1):48-54.
Barbour MM, Hume AL, Lapane KL, Derby CA, Carleton RA. Predictors of future antihypertensive use in patients with mildly elevated blood pressure. Pharmacotherapy. 1995 May-Jun; 15(3):272-8.
Weitzen S, Lapane KL, Toledano AY, Hume AL, Mor V. Weaknesses of goodness-of-fit tests for evaluating propensity score models: the case of the omitted confounder. Pharmacoepidemiol Drug Saf. 2005 Apr; 14(4):227-38.
Derby CA, Lapane KL, Feldman HA, Carleton RA. Trends in validated cases of fatal and nonfatal stroke, stroke classification, and risk factors in southeastern New England, 1980 to 1991 : data from the Pawtucket Heart Health Program. Stroke. 2000 Apr; 31(4):875-81.
Bostom AG, Shemin D, Lapane KL, Nadeau MR, Sutherland P, Chan J, Rozen R, Yoburn D, Jacques PF, Selhub J, Rosenberg IH. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients. Atherosclerosis. 1996 Jun; 123(1-2):193-202.
Hume AL, Barbour MM, Willey CJ, Assaf AR, Lapane KL, Carleton RA. Changing trends in antihypertensive therapy in two New England communities during the 1980s. Pharmacotherapy. 1993 May-Jun; 13(3):244-51.